Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism

Senthilkumar Karuppagounder, Karuppagounder S. Saravanan, Goutam Chandra, Kizhakke M. Sindhu, A. Jayakrishnan, Kochupurackal P. Mohanakumar

Research output: Contribution to journalArticle

Abstract

Dopaminergic functional recovery following controlled release of dopamine from biodegradable polymer matrices implanted in the lesioned striatum was investigated in a hemiparkinsonian animal model. Significant dopamine depletion in the striatum ipsilateral to the side of infusion was observed in animals unilaterally infused with 6-hydroxydopamine (6-OHDA) in the substatia nigra. These animals displayed apomorphine-induced contralateral rotational behavior, when examined on the 16th day. Implantation of a controlled release delivery system (hydrogel obtained by mixing dextran dialdehyde cross-linked with gelatin) containing dopamine in the denervated striatum on the 1st day or the 18th day significantly abolished the apomorphine-induced contralateral rotational behavior in these animals. The recovery was visible for about 17 days, thereafter the behavioral bias reappeared. The present results indicate that dopamine released from the polymer matrices alleviates behavioral bias in experimental parkinsonism, implying use of such technologies as an alternative method for the treatment of Parkinson's disease. This approach is useful in reducing the oral dose of drugs that are with severe systemic effects, and that develop tolerance.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalBehavioural Brain Research
Volume184
Issue number1
DOIs
StatePublished - Nov 22 2007
Externally publishedYes

Fingerprint

Hydrogel
Oxidopamine
Parkinsonian Disorders
Dopamine
Apomorphine
Polymers
Animal Behavior
Gelatin
Parkinson Disease
Animal Models
Technology
Pharmaceutical Preparations

Keywords

  • 6-Hydroxydopamine
  • Apomorphine
  • Controlled release
  • Dextran dialdehyde cross-linked gelatin hydrogel
  • Dopamine
  • Parkinson's disease
  • Rotational behavior
  • Striatal implantation

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism. / Karuppagounder, Senthilkumar; Saravanan, Karuppagounder S.; Chandra, Goutam; Sindhu, Kizhakke M.; Jayakrishnan, A.; Mohanakumar, Kochupurackal P.

In: Behavioural Brain Research, Vol. 184, No. 1, 22.11.2007, p. 11-18.

Research output: Contribution to journalArticle

Karuppagounder, Senthilkumar ; Saravanan, Karuppagounder S. ; Chandra, Goutam ; Sindhu, Kizhakke M. ; Jayakrishnan, A. ; Mohanakumar, Kochupurackal P. / Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism. In: Behavioural Brain Research. 2007 ; Vol. 184, No. 1. pp. 11-18.
@article{2c86ba8618f0461cab3f7cae20e0f353,
title = "Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism",
abstract = "Dopaminergic functional recovery following controlled release of dopamine from biodegradable polymer matrices implanted in the lesioned striatum was investigated in a hemiparkinsonian animal model. Significant dopamine depletion in the striatum ipsilateral to the side of infusion was observed in animals unilaterally infused with 6-hydroxydopamine (6-OHDA) in the substatia nigra. These animals displayed apomorphine-induced contralateral rotational behavior, when examined on the 16th day. Implantation of a controlled release delivery system (hydrogel obtained by mixing dextran dialdehyde cross-linked with gelatin) containing dopamine in the denervated striatum on the 1st day or the 18th day significantly abolished the apomorphine-induced contralateral rotational behavior in these animals. The recovery was visible for about 17 days, thereafter the behavioral bias reappeared. The present results indicate that dopamine released from the polymer matrices alleviates behavioral bias in experimental parkinsonism, implying use of such technologies as an alternative method for the treatment of Parkinson's disease. This approach is useful in reducing the oral dose of drugs that are with severe systemic effects, and that develop tolerance.",
keywords = "6-Hydroxydopamine, Apomorphine, Controlled release, Dextran dialdehyde cross-linked gelatin hydrogel, Dopamine, Parkinson's disease, Rotational behavior, Striatal implantation",
author = "Senthilkumar Karuppagounder and Saravanan, {Karuppagounder S.} and Goutam Chandra and Sindhu, {Kizhakke M.} and A. Jayakrishnan and Mohanakumar, {Kochupurackal P.}",
year = "2007",
month = "11",
day = "22",
doi = "10.1016/j.bbr.2007.06.025",
language = "English (US)",
volume = "184",
pages = "11--18",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism

AU - Karuppagounder, Senthilkumar

AU - Saravanan, Karuppagounder S.

AU - Chandra, Goutam

AU - Sindhu, Kizhakke M.

AU - Jayakrishnan, A.

AU - Mohanakumar, Kochupurackal P.

PY - 2007/11/22

Y1 - 2007/11/22

N2 - Dopaminergic functional recovery following controlled release of dopamine from biodegradable polymer matrices implanted in the lesioned striatum was investigated in a hemiparkinsonian animal model. Significant dopamine depletion in the striatum ipsilateral to the side of infusion was observed in animals unilaterally infused with 6-hydroxydopamine (6-OHDA) in the substatia nigra. These animals displayed apomorphine-induced contralateral rotational behavior, when examined on the 16th day. Implantation of a controlled release delivery system (hydrogel obtained by mixing dextran dialdehyde cross-linked with gelatin) containing dopamine in the denervated striatum on the 1st day or the 18th day significantly abolished the apomorphine-induced contralateral rotational behavior in these animals. The recovery was visible for about 17 days, thereafter the behavioral bias reappeared. The present results indicate that dopamine released from the polymer matrices alleviates behavioral bias in experimental parkinsonism, implying use of such technologies as an alternative method for the treatment of Parkinson's disease. This approach is useful in reducing the oral dose of drugs that are with severe systemic effects, and that develop tolerance.

AB - Dopaminergic functional recovery following controlled release of dopamine from biodegradable polymer matrices implanted in the lesioned striatum was investigated in a hemiparkinsonian animal model. Significant dopamine depletion in the striatum ipsilateral to the side of infusion was observed in animals unilaterally infused with 6-hydroxydopamine (6-OHDA) in the substatia nigra. These animals displayed apomorphine-induced contralateral rotational behavior, when examined on the 16th day. Implantation of a controlled release delivery system (hydrogel obtained by mixing dextran dialdehyde cross-linked with gelatin) containing dopamine in the denervated striatum on the 1st day or the 18th day significantly abolished the apomorphine-induced contralateral rotational behavior in these animals. The recovery was visible for about 17 days, thereafter the behavioral bias reappeared. The present results indicate that dopamine released from the polymer matrices alleviates behavioral bias in experimental parkinsonism, implying use of such technologies as an alternative method for the treatment of Parkinson's disease. This approach is useful in reducing the oral dose of drugs that are with severe systemic effects, and that develop tolerance.

KW - 6-Hydroxydopamine

KW - Apomorphine

KW - Controlled release

KW - Dextran dialdehyde cross-linked gelatin hydrogel

KW - Dopamine

KW - Parkinson's disease

KW - Rotational behavior

KW - Striatal implantation

UR - http://www.scopus.com/inward/record.url?scp=34548668709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548668709&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2007.06.025

DO - 10.1016/j.bbr.2007.06.025

M3 - Article

C2 - 17765334

AN - SCOPUS:34548668709

VL - 184

SP - 11

EP - 18

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1

ER -